(Q33935032)

30 July 2017

title

Novel PPARγ partial agonists with weak activity and no cytotoxicity; identified by a simple PPARγ ligand screening system (English)

1 reference

30 July 2017

Min-Chul Cho

1

1 reference

30 July 2017

Dong-Hun Lee

2

1 reference

30 July 2017

Eun Jin Kim

3

1 reference

30 July 2017

Jee-young Lee

4

1 reference

30 July 2017

Jeong-Woo Kang

5

1 reference

30 July 2017

Jong Hwan Song

6

1 reference

30 July 2017

Youhoon Chong

7

1 reference

30 July 2017

Yangmi Kim

8

1 reference

30 July 2017

Jin-Tae Hong

9

1 reference

30 July 2017

Do-Young Yoon

10

1 reference

30 July 2017

language of work or name

1 reference

17 June 2011

1 reference

Molecular and Cellular Biochemistry

30 July 2017

published in

1 reference

30 July 2017

volume

358

1 reference

30 July 2017

issue

1-2

1 reference

30 July 2017

page(s)

75-83

1 reference

https://scigraph.springernature.com/pub.10.1007/s11010-011-0923-1

30 July 2017

exact match

0 references

cites work

Orphan nuclear receptors: from gene to function

1 reference

https://api.crossref.org/works/10.1007%2FS11010-011-0923-1

PPARgamma: an essential regulator of adipogenesis and modulator of fat cell function

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-011-0923-1

Peroxisome proliferator-activated receptors: nuclear control of metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-011-0923-1

Peroxisome proliferator-activated receptor gamma and metabolic disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-011-0923-1

Peroxisome proliferator-activated receptors alpha and gamma are activated by indomethacin and other non-steroidal anti-inflammatory drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-011-0923-1

Peroxisome proliferator-activated receptor gamma (PPARgamma) and its ligands: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-011-0923-1

Adipocyte-specific transcription factor ARF6 is a heterodimeric complex of two nuclear hormone receptors, PPAR gamma and RXR alpha

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-011-0923-1

mPPAR gamma 2: tissue-specific regulator of an adipocyte enhancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-011-0923-1

Ligand binding and co-activator assembly of the peroxisome proliferator-activated receptor-gamma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-011-0923-1

A signature motif in transcriptional co-activators mediates binding to nuclear receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-011-0923-1

5-(3,5-Di-tert-butyl-4-hydroxybenzylidene) thiazolidine-2,4-dione modulates peroxisome proliferators-activated receptor gamma in 3T3-L1 adipocytes: roles as a PPARgamma ligand

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-011-0923-1

A simple method to screen ligands of peroxisome proliferator-activated receptor delta.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-011-0923-1

Optimization of an enzyme-linked immunosorbent assay to screen ligand of Peroxisome proliferator-activated receptor alpha.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-011-0923-1

Transcription coactivators for peroxisome proliferator-activated receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-011-0923-1

PPARs: therapeutic targets for metabolic disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-011-0923-1

Peroxisome proliferator-activated receptor-gamma calls for activation in moderation: lessons from genetics and pharmacology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-011-0923-1

Peroxisome proliferator-activated receptor structures: ligand specificity, molecular switch and interactions with regulators.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-011-0923-1

Virtual Screening as a Technique for PPAR Modulator Discovery

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-011-0923-1

The new antidiabetic drug MCC-555 acutely sensitizes insulin signaling in isolated cardiomyocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-011-0923-1

A potent antidiabetic thiazolidinedione with unique peroxisome proliferator-activated receptor gamma-activating properties

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-011-0923-1

Identification of telmisartan as a unique angiotensin II receptor antagonist with selective PPARgamma-modulating activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-011-0923-1

Molecular characterization of new selective peroxisome proliferator-activated receptor gamma modulators with angiotensin receptor blocking activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-011-0923-1

Halofenate is a selective peroxisome proliferator-activated receptor gamma modulator with antidiabetic activity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-011-0923-1

Selective Modulators of PPAR-gamma Activity: Molecular Aspects Related to Obesity and Side-Effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-011-0923-1

FK614, a novel peroxisome proliferator-activated receptor gamma modulator, induces differential transactivation through a unique ligand-specific interaction with transcriptional coactivators

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-011-0923-1

Pharmacological characteristics of a novel nonthiazolidinedione insulin sensitizer, FK614.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-011-0923-1

PPAR agonists: multimodal drugs for the treatment of type-2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-011-0923-1

Discovery of (2R)-2-(3-{3-[(4-Methoxyphenyl)carbonyl]-2-methyl-6-(trifluoromethoxy)-1H-indol-1-yl}phenoxy)butanoic acid (MK-0533): a novel selective peroxisome proliferator-activated receptor gamma modulator for the treatment of type 2 diabetes mell

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-011-0923-1

A comparison of glycemic control, water retention, and musculoskeletal effects of balaglitazone and pioglitazone in diet-induced obese rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-011-0923-1

Structural determinants of ligand binding selectivity between the peroxisome proliferator-activated receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-011-0923-1

PPARgamma as a new therapeutic target in inflammatory bowel diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-011-0923-1

Epitope analysis of PPARgamma monoclonal antibody Pgamma48.34A and its application for screening PPARgamma ligands

21 January 2018

1 reference

12 December 2020

Structure-based design of indole propionic acids as novel PPARalpha/gamma co-agonists

1 reference

12 December 2020

Peroxisome Proliferators-Activated Receptor (PPAR) Modulators and Metabolic Disorders

1 reference

12 December 2020

The coregulator exchange in transcriptional functions of nuclear receptors

1 reference

12 December 2020

10.1007/S11010-011-0923-1

Identifiers

DOI

1 reference

Dimensions Publication ID

30 July 2017

1052776349

0 references

Fatcat ID

release_l7222afzhnelzooifdjbhja2za

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/l7222afzhnelzooifdjbhja2za

24 November 2022

mapped directly with Wikidata item

1 reference